Management of people with early or very early stage hepatocellular carcinoma: an attempted network meta-analysis

[1]  D. Thorburn,et al.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis. , 2017, The Cochrane database of systematic reviews.

[2]  J. Gong,et al.  Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review , 2016, Therapeutics and clinical risk management.

[3]  Mohammad Hassan Murad,et al.  A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.

[4]  P. Bie,et al.  Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials. , 2014, Hepato-gastroenterology.

[5]  W. Dong,et al.  Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. , 2014, World journal of gastroenterology.

[6]  Michael F. McNeeley,et al.  Hepatocellular carcinoma in the noncirrhotic liver. , 2014, AJR. American journal of roentgenology.

[7]  K. Gurusamy,et al.  Methods of preventing bacterial sepsis and wound complications after liver transplantation. , 2014, The Cochrane database of systematic reviews.

[8]  D. Fan,et al.  Radiofrequency Ablation Versus Hepatic Resection for Small Hepatocellular Carcinoma: A Meta-analysis of Randomized Controlled Trials , 2013, Journal of clinical gastroenterology.

[9]  Christoph Flückiger,et al.  Efficacy of New Generation Antidepressants: Differences Seem Illusory , 2013, PloS one.

[10]  Iztok Hozo,et al.  Trial Sequential Boundaries for Cumulative Meta-Analyses , 2013 .

[11]  Shaunagh McDermott,et al.  Radiofrequency Ablation of Liver Tumors , 2013, Seminars in Interventional Radiology.

[12]  Nicky J Welton,et al.  Automating network meta‐analysis , 2012, Research synthesis methods.

[13]  Kristian Thorlund,et al.  How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.

[14]  Alex J. Sutton,et al.  Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .

[15]  Nicky J Welton,et al.  NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2011 .

[16]  Deborah M Caldwell,et al.  NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. , 2011 .

[17]  Nicky J Welton,et al.  NICE DSU Technical Support Document 1: Introduction to Evidence Synthesis for Decision Making , 2011 .

[18]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[19]  J. Wetterslev,et al.  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. , 2011, The Cochrane database of systematic reviews.

[20]  S Dias,et al.  Checking consistency in mixed treatment comparison meta‐analysis , 2010, Statistics in medicine.

[21]  Kurinchi Gurusamy,et al.  Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. , 2010, Journal of hepatology.

[22]  D. Geller,et al.  World Review of Laparoscopic Liver Resection—2,804 Patients , 2009, Annals of surgery.

[23]  R. Brant,et al.  Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[24]  A. Burroughs,et al.  TACE versus TAE as therapy for hepatocellular carcinoma , 2008, Expert review of anticancer therapy.

[25]  H. El‐Serag,et al.  Oral contraception and the risk of hepatocellular carcinoma. , 2007, Journal of hepatology.

[26]  Alessandro Vitale,et al.  Prospective validation of the Barcelona Clinic Liver Cancer staging system. , 2006, Journal of hepatology.

[27]  T. Nagayasu,et al.  Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy , 2006, Journal of Gastroenterology.

[28]  K. McGlynn,et al.  Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. , 2004, Gastroenterology.

[29]  Pamela Royle,et al.  LITERATURE SEARCHING FOR RANDOMIZED CONTROLLED TRIALS USED IN COCHRANE REVIEWS: RAPID VERSUS EXHAUSTIVE SEARCHES , 2003, International Journal of Technology Assessment in Health Care.

[30]  S D Walter,et al.  A comparison of methods to detect publication bias in meta‐analysis , 2001, Statistics in medicine.

[31]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[32]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[33]  D J Newell,et al.  Intention-to-treat analysis: implications for quantitative and qualitative research. , 1992, International journal of epidemiology.

[34]  C. la Vecchia,et al.  The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[36]  John E. Ware,et al.  SF-36 Health Survey. , 1990 .